Gennady Bratslavsky

12PUBLICATIONS
59CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 04, 2026
131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.

Evan Y Yu, Vivek Narayan, Giuseppe Esposito

|Jan 12, 2026
Targeting and dissociating HIF2α from the molecular chaperone Hsp70 triggers apoptosis in kidney cancer.

Jennifer A Heritz, Sarah J Backe, Angela Pacherille

|Nov 20, 2024
Metastasis development in non-muscle-invasive bladder cancer.

Michael Leyderman, Thenappan Chandrasekar, Petros Grivas

|Aug 16, 2024
Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study.

Antonio Cigliola, Alina Basnet, Joseph M Jacob

|Jun 10, 2023
The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma.

Megan Ngai, Thenappan Chandrasekar, Gennady Bratslavsky

|Nov 11, 2022
In Vivo Models for Prostate Cancer Research.

Robert Adamiecki, Anita Hryniewicz-Jankowska, Maria A Ortiz

Pageof 2